New Drug Reviews
1 Results
- Pharmacotherapy New drug review
Belimumab: Review of Use in Systemic Lupus Erythematosus
Clinical TherapeuticsVol. 34Issue 5p1006–1022Published online: April 5, 2012- Eric G. Boyce
- Bryan E. Fusco
Cited in Scopus: 27Belimumab, a monoclonal antibody that inhibits B-lymphocyte stimulating protein, was the first biologic agent approved for, and the first drug approved in 55 years for, the treatment of systemic lupus erythematosus (SLE) by the US Food and Drug Administration (FDA).
